Analyst Ratings for Mereo BipPharma Group (MREO)

MREO Rating Summary

MREO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MREO
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $1.75 (+525%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/18/2026 JPMorgan Priyanka Grover Downgrade Underweight
(Neutral)
N/A
(N/A)
0.31
(0.28)
-9.68% Details
12/30/2025 Jefferies Maury Raycroft Downgrade Hold
(Buy)
0.50
(7.00)
2.31
(0.28)
-87.88% Details